BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9419495)

  • 1. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
    Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
    Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
    Gehl HB; Vorwerk D; Klose KC; Günther RW
    Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
    Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
    Gong J; Xu J; Zhou K; Shen K
    Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
    Ni Y; Petré C; Bosmans H; Miao Y; Grant D; Baert AL; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):700-7. PubMed ID: 9245965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
    Wang C; Gordon PB; Hustvedt SO; Grant D; Sterud AT; Martinsen I; Ahlström H; Hemmingsson A
    Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
    J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
    Diehl SJ; Lehmann KJ; Gaa J; McGill S; Hoffmann V; Georgi M
    Invest Radiol; 1999 Sep; 34(9):589-95. PubMed ID: 10485075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
    Young SW; Simpson BB; Ratner AV; Matkin C; Carter EA
    Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
    Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
    Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP.
    Coley BD; Mattrey RF; Baker KG; Peterson T; Burgan AR
    J Magn Reson Imaging; 1995; 5(1):11-6. PubMed ID: 7696800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
    Bernardino ME; Young SW; Lee JK; Weinreb JC
    Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functioning acinar cell pancreatic carcinoma: diagnosis on mangafodipir trisodium (Mn-DPDP)-enhanced MRI.
    Sahani D; Prasad SR; Maher M; Warshaw AL; Hahn PF; Saini S
    J Comput Assist Tomogr; 2002; 26(1):126-8. PubMed ID: 11801915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
    Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D
    Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
    Ni Y; Petré C; Lukito G; Marchal G; Grant D; Gray TJ; Baert AL
    Acad Radiol; 1995 Apr; 2(4):300-5. PubMed ID: 9419566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.
    Boraschi P; Donati F; Gigoni R; Caramella D; Boggi U; Falaschi F; Bartolozzi C
    Eur Radiol; 2006 May; 16(5):988-97. PubMed ID: 16421713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
    Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF
    Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.